Subscribe to our Newsletters !!
There is one fact about life on Earth we cannot es
The IND360 product family from METTLER TOLEDO offe
The Nobel Prize in Physiology or Medicine awarded
Shilpa Medicare – the full-service contract de
Alembic Pharmaceutica
Tofu has been a favorite food for vegetarians and
Dear Readers, Welcome to the latest issue of Mi
Finally, Indian pharma companies are finding a way to enter the world’s second largest pharmaceutical market which is attractive and profitable market of China. Usually it takes 5 years to get n approval but the Indian drug regulators get the approval for the drug product within 3-6 months.
“They (the China Food and Drug Administration, or CFDA) are very clear about expediting entry of Indian generic pharmaceuticals,” said Dinesh Dua, Chairman of Pharmaceuticals Export Promotion Council (Pharmexcil) “They will follow the dossier whatever written in the Drug Master File (DMF), and if everything is found alright they will then expedite approval without ifs and buts,” Dua said.
Dua also said that Pharmexcil had meeting with the CFDA, Chinese Chamber of Commerce and other industrial bodies.Whereas soon a Delegation from CFDA will visit India for providing more clarification and educating us that what Chinese drug regulator expects. “The ground work has started, China is our top focus for exports,” Dua added.
